POINT Biopharma Reports Fiscal 2021 Financial Results and
Reported 27-patient dosimetry data from the lead-in cohort of the SPLASH trial Randomization phase of SPLASH trial ongoing, top line data expected...
Source: globenewswire.com
📰 Isotope Development News
Isotope Development News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Isotope Development. Real-time updates on events, politics, business and more.
POINT Biopharma adds a COO, Further Strengthens Leadership
Justyna Kelly promoted to COO, Dr. Robin Hallett promoted to VP, Discovery and Translational Sciences, Dr. Sherin Al-Safadi to join as VP Medical Affairs,...
Source: globenewswire.com